Plasma Cell precursor and Other Disorders
Safety and Efficacy of Elranatamab in Patients with Relapsed or Refractory AL Amyloidosis: A Retrospective Case Series
Pedro G. Vianna, MD (he/him/his)
Clinical Instructor in Medicine, Associate Physician Division of Hematology
Brigham and Women's Hospital/ Dana Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States